Additionally, ACSS2 null mice are phenotypically normal, without embryonical or developmental deficiencies, suggesting that ACSS2 may be a non-essential gene under normal conditions (Huang et al., 2018), making ACSS2 an attractive cancer-specific target. This evidence concerns the gene ACSS2 and cancer.